PATENT CLAIM ANALYSIS

Application Number: 15971692
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "014200"]

Abstract:
This invention relates pro-coagulant serpin molecules engineered by modification of the P4, P2, P1 and/or P1′ residues within the reactive center loop (RCL) to display increased specificity for anticoagulant proteases. These modified serpin molecules may be useful in therapy, for example as pro-coagulants for the treatment of bleeding.

Claim (Index 15):
A pharmaceutical composition comprising a modified serpin according to  claim 1  and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15103420', '11825627', '15034385', '12676203', '12179951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6361433965718082
- 35 USC 102 Novelty (BERT): 0.6520446575545713
- Combined Prediction Score: 0.6377335226700845
- Mean Citation Score: 310.5061740000001
- Max Citation Score: 645.6493
- Similarity Product: 577.0773550891637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test